News
Key Takeaways From Quest Diagnostics Analyst Ratings
20 Mar 24
Analyst Ratings
Truist Securities Reiterates Hold on Quest Diagnostics, Maintains $145 Price Target
20 Mar 24
News, Price Target, Reiteration, Analyst Ratings
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
18 Mar 24
News, Top Stories, General
(DGX) - Analyzing Quest Diagnostics's Short Interest
5 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
26 Feb 24
Analyst Ratings
Leerink Partners Initiates Coverage On Quest Diagnostics with Market Perform Rating, Announces Price Target of $135
26 Feb 24
News, Price Target, Initiation, Analyst Ratings
Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the US with Integrated Patient Health Coaching and Nutritious Grocery Delivery
21 Feb 24
News
Quest Diagnostics Launch MelaNodal Predict Test For Melanoma
13 Feb 24
Biotech, News, General
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
7 Feb 24
News, Penny Stocks, Price Target, Small Cap, Markets, Analyst Ratings, Trading Ideas
Jefferies Upgrades Quest Diagnostics to Buy, Raises Price Target to $155
7 Feb 24
News, Upgrades, Price Target, Analyst Ratings
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
2 Feb 24
Analyst Ratings
Truist Securities Maintains Hold on Quest Diagnostics, Lowers Price Target to $145-Report Released on 1 February 2024
2 Feb 24
News, Price Target, Analyst Ratings
Quest Diagnostics Q4 Adjusted EPS $2.15 Beats $2.11 Estimate, Sales $2.29B Beat $2.25B Estimate
1 Feb 24
Earnings, News
Earnings Scheduled For February 1, 2024
1 Feb 24
Earnings
Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points
1 Feb 24
Earnings, News, Federal Reserve, Pre-Market Outlook, Markets, Trading Ideas
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1 Feb 24
Earnings, News, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Earnings Outlook For Quest Diagnostics
31 Jan 24
Earnings
Press releases
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
2 Apr 24
Press Releases
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
26 Mar 24
Press Releases
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
19 Mar 24
Press Releases
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
23 Feb 24
Press Releases
Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery
21 Feb 24
Press Releases
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
15 Feb 24
Press Releases
Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery
13 Feb 24
Press Releases
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
12 Feb 24
Press Releases
Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
1 Feb 24
Earnings, Press Releases
Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"
31 Jan 24
Press Releases
Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma
22 Jan 24
Press Releases